2025

• Lin, A., Kench, J., Young, C. (2025). Eosinophilic myenteric ganglionitis presenting with constipation and erythema ab igne: a case report. ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY, 10, 8. [More Information]
• Ly, M., Lau, N., Dennis, C., Chen, J., Risbey, C., Tan, S., Chen, R., Wang, C., Gorrell, M., McKenzie, C., Kench, J., Liu, K., McCaughan, G., Crawford, M., Pulitano, C. (2025). Long Term Ex-Situ Normothermic Machine Perfusion Allows Regeneration of Human Livers with Severe Bile Duct Injury. American Journal Of Transplantation, 25(1), 60-71. [More Information]

2024

• Gallagher, B., Chiam, K., Bang, S., Patel, M., Kench, J., Edwards, S., Nair-Shalliker, V., Smith, D. (2024). Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. Pathology, 56(1), 39-46. [More Information]
• Tang, L., Chetwood, J., Lai, M., Yip, T., Cao, R., Powter, E., Salimi, S., Wu, R., Coulshed, A., Bowen, D., Strasser, S., Crawford, M., Pulitano, C., McKenzie, C., Kench, J., McCaughan, G., Liu, K., et al (2024). Incidence, epidemiology and outcomes of acute allograft rejection following liver transplantation in Australia. Liver Transplantation, 30(10), 1039-1049. [More Information]
• Tang, L., Bowen, D., Strasser, S., Valliani, T., Crawford, M., Pulitano, C., McKenzie, C., Kench, J., McCaughan, G., Liu, K., Chetwood, J., et al (2024). Incidence, epidemiology, and outcomes of acute allograft rejection following liver transplantation in Australia. Liver Transplantation, 30(10), 1039-1049. [More Information]

2023

• Nash, E., Kench, J., Watson, G., Liu, K. (2023). A case of drug reaction with eosinophilia and systemic symptoms (DRESS) due to rivaroxaban. Pathology, 55(7), 1022-1024. [More Information]
• Bonazzi, V., Keane, C., Gebski, V., Kench, J., Goldstein, D., Waddell, N., Barbour, A., Aoude, L., Brosda, S., Bradford, J., et al (2023). C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology. [More Information]
• Ly, M., Lau, N., McKenzie, C., Kench, J., McCaughan, G., Crawford, M., Pulitano, C. (2023). Does an Additional Bile Duct Flush with Low-viscosity Preservation Solution Reduce Bile Duct Injury? A Single-blinded Randomized Clinical Trial. Transplantation Direct, 9(3), E1443. [More Information]
• Ly, M., Lau, N., McKenzie, C., Kench, J., Seyfi, D., Majumdar, A., Liu, K., McCaughan, G., Crawford, M., Pulitano, C. (2023). Histological Assessment of the Bile Duct before Liver Transplantation: Does the Bile Duct Injury Score Predict Biliary Strictures? Journal of Clinical Medicine, 12(21), 6793. [More Information]
• Lau, N., Ly, M., Dennis, C., Ewenson, K., Ly, H., Huang, J., Cabanes Creus, M., Chanda, S., Wang, C., Lisowski, L., Liu, K., Kench, J., McCaughan, G., Pulitano, C., et al (2023). Liver splitting during normothermic machine perfusion: a novel method to combine the advantages of both in-situ and ex-vivo techniques. HPB, 25(5), 543-555. [More Information]
• Lau, N., Ly, M., Dennis, C., Jacques, A., Cabanes Creus, M., Toomath, S., Huang, J., Mestrovic, N., Yousif, P., Chanda, S., Wang, C., Lisowski, L., Liu, K., Kench, J., McCaughan, G., Crawford, M., Pulitano, C. (2023). Long-term ex situ normothermic perfusion of human split livers for more than 1 week. Nature Communications, 14(1). [More Information]
• McKenzie, C., Karim, R., Kench, J., Klebe, S., Kramer, N., Kumarasinghe, M., Maclean, F., Morey, A., Nguyen, M., O'Toole, S., Gupta, R., Salisbury, E., Scolyer, R., Cooper, W., Anderson, L., Chen, V., et al (2023). Looking beyond workforce parity: addressing gender inequity in pathology. Pathology, 55(6), 760-771. [More Information]
• Liu, K., Chen, J., Zhao, Y., Boland, J., Ting, K., Lockwood, G., McKenzie, C., Kench, J., Vadas, M., Gamble, J., McCaughan, G. (2023). Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate. Frontiers in Immunology, 14, 1245708. [More Information]

2022

• Jaratlerdsiri, W., Jiang, J., Gong, T., Patrick, S., Willet, C., Chew, T., Lyons, R., Haynes, A., Pasqualim, G., Louw, M., Sadsad, R., Hayes, V., et al (2022). African-specific molecular taxonomy of prostate cancer. Nature, 609(7927), 552-559. [More Information]
• Dennis, C., Prince, D., Moayed-Alaei, L., Remash, D., Carr-Boyd, E., Bowen, D., Strasser, S., Crawford, M., Pulitano, C., Kench, J., McCaughan, G., McKenzie, C., Liu, K. (2022). Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation. Frontiers in Oncology, 12. [More Information]
• Chen, J., Cheng, N., Boland, J., Liu, K., Kench, J., Watkins, D., Ferreira-Gonzalez, S., Forbes, S., McCaughan, G. (2022). Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1868 (4), 166335. [More Information]
• Lau, N., Ly, M., Dennis, C., Liu, K., Kench, J., Crawford, M., Pulitano, C. (2022). Long-term normothermic perfusion of human livers for longer than 12 days. Artificial Organs, 46(12), 2504-2510. [More Information]
• Steinberg, J., Chan, P., Hogden, E., Tiernan, G., Morrow, A., Kang, Y., He, E., Venchiarutti, R., Titterton, L., Sankey, L., Mckay, S., Engel, A., Kench, J., Solomon, M., Toh, J., Canfell, K., et al (2022). Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Hereditary Cancer in Clinical Practice, 20(1), 18. [More Information]
• Ioannou, L., Maharaj, A., Zalcberg, J., Loughnan, J., Croagh, D., Pilgrim, C., Goldstein, D., Kench, J., Merrett, N., Earnest, A., White, K., et al (2022). Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. HPB, 24(8), 1201-1216. [More Information]
• Maharaj, A., Evans, S., Ioannou, L., Croagh, D., Earnest, A., Holland, J., Pilgrim, C., Neale, R., Goldstein, D., Kench, J., White, K., et al (2022). The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. HPB, 24(6), 950-962. [More Information]
• Ly, M., Lau, N., McKenzie, C., Kench, J., McCaughan, G., Crawford, M., Pulitano, C. (2022). The Delay of Arterialization After Initial Portal Reperfusion More Than Warm Ischemia Time May Determine Ischemic-type Biliary Injury. Transplantation, 106(2), E167-E168. [More Information]
• Kench, J., Amin, M., Berney, D., Compérat, E., Cree, I., Gill, A., Hartmann, A., Menon, S., Moch, H., Netto, G., et al (2022). WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. [More Information]

2021

• Bulten, W., Balkenhol, M., Belinga, J., Brilhante, A., Çak?r, A., Egevad, L., Eklund, M., Farré, X., Geronatsiou, K., Molinié, V., et al (2021). Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Modern Pathology, 34(3), 660-671. [More Information]
• Maharaj, A., Evans, S., Zalcberg, J., Ioannou, L., Graco, M., Croagh, D., Pilgrim, C., Dodson, T., Goldstein, D., Philip, J., Kench, J., et al (2021). Barriers and enablers to the implementation of multidisciplinary team meetings: A qualitative study using the theoretical domains framework. BMJ Quality and Safety, 30(10), 792-803. [More Information]
• Verbeke, C., Webster, F., Brosens, L., Campbell, F., Del Chiaro, M., Esposito, I., Feakins, R., Fukushima, N., Gill, A., Kakar, S., Kench, J., et al (2021). Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 79(6), 902-912. [More Information]
• Henderson, J., Xiang, M., Huang, C., Wetzel, S., Jiang, L., Lai, J., Wu, W., Kench, J., Bachovchin, W., Roediger, B., McCaughan, G., Zhang, H., Gorrell, M. (2021). Dipeptidyl peptidase inhibition enhances cd8 t cell recruitment and activates intrahepatic inflammasome in a murine model of hepatocellular carcinoma. Cancers, 13(21), 5495. [More Information]
• Delahunt, B., Egevad, L., Samaratunga, H., Srigley, J., Cheng, L., Clouston, D., Furusato, B., Kench, J., Leite, K., MacLennan, G., et al (2021). Intraductal carcinoma of the prostate is not a diagnostic entity. Histopathology, 78(2), 342-344. [More Information]
• Ferguson, P., Kench, J., Watson, G. (2021). Intranuclear inclusions are a distinguishing morphological feature of renal cell carcinoma with leiomyomatous stroma. Pathology, 53(4), 543-545. [More Information]
• Butler, L., Mah, C., Machiels, J., Vincent, A., Irani, S., Mutuku, S., Spotbeen, X., Bagadi, M., Waltregny, D., Moldovan, M., Kench, J., Horvath, L., et al (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993. [More Information]
• Ke, H., Gill, A., McKenzie, C., Kench, J., Chan, R., Pavlakis, N., Fulham, M., Koh, C., Kao, S. (2021). Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report. JTO Clinical and Research Reports, 2(11), 100236. [More Information]
• Lau, N., Ly, M., Jacques, A., Ewenson, K., Mestrovic, N., Almoflihi, A., Koutalistras, N., Liu, K., Kench, J., McCaughan, G., et al (2021). Prolonged Ex Vivo Normothermic Perfusion of a Split Liver: An Innovative Approach to Increase the Number of Available Grafts. Transplantation Direct, 7(10), e763. [More Information]
• Egevad, L., Delahunt, B., Bostwick, D., Cheng, L., Evans, A., Gianduzzo, T., Graefen, M., Hugosson, J., Kench, J., Leite, K., et al (2021). Prostate Cancer Grading, Time To Go Back To the Future. BJU International, 127(2), 165-168. [More Information]
• Than, N., Chin, S., Kench, J., McCaughan, G., Majumdar, A. (2021). Steroid-refractory T-cell mediated rejection after human metapneumovirus infection in a liver transplant recipient. Pathology, 53(6), 793-794. [More Information]
• Chiam, K., Carle, C., Hughes, S., Kench, J., Woo, H., Lord, S., Smith, D. (2021). Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios. Prostate Cancer and Prostatic Diseases, 24(3), 662-673. [More Information]

2020

• Ström, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D., Bostwick, D., Evans, A., Grignon, D., Humphrey, P., Kench, J., et al (2020). Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. The Lancet Oncology, 21(2), 222-232. [More Information]
• Maharaj, A., Evans, S., Zalcberg, J., Ioannou, L., Graco, M., Croagh, D., Pilgrim, C., Dodson, T., Goldstein, D., Philip, J., White, K., et al (2020). Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. PloS One, 15, e0243312. [More Information]
• Egevad, L., Swanberg, D., Delahunt, B., Ström, P., Kartasalo, K., Olsson, H., Berney, D., Bostwick, D., Evans, A., Humphrey, P., Kench, J., et al (2020). Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading. Virchows Archiv, 477(6), 777-786. [More Information]
• Samaratunga, H., Delahunt, B., Egevad, L., Srigley, J., Billis, A., Bostwick, D., Camparo, P., Cheng, L., Clouston, D., Denham, J., Kench, J., et al (2020). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52(2), 192-196. [More Information]
• Feletto, E., Lew, J., Worthington, J., He, E., Caruana, M., Butler, K., Hui, H., Taylor, N., Banks, E., Barclay, K., Grogan, P., Kench, J., Taoube, L., Ward, R., Armstrong, B., Canfell, K., et al (2020). Pathways to a cancer-free future: A protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. BMJ Open, 10(6), 1-9. [More Information]
• Scheinberg, T., Kench, J., Stockler, M., Mahon, K., Sebastian, L., Stricker, P., Joshua, A., Woo, H., Thanigasalam, R., Ahmadi, N., Horvath, L., et al (2020). Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: A study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer). BMJ Open, 10(1), e033667. [More Information]
• Gandhi, J., Smith, S., Paner, G., McKenney, J., Sekhri, R., Osunkoya, A., Baras, A., DeMarzo, A., Cheville, J., Jimenez, R., Kench, J., et al (2020). Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. The American Journal of Surgical Pathology, 44(5), 673-680. [More Information]
• Bailey, M., Meyerson, W., Dursi, L., Wang, L., Dong, G., Liang, W., Weerasinghe, A., Li, S., Burke, H., Chiew, Y., Chou, A., Dagg, R., De Paoli-Iseppi, R., Gill, A., Hayward, N., Hersey, P., Jakrot, V., Kakavand, H., Kench, J., Kennedy, C., Mann, G., Pupo, G., Samra, J., Schramm, S., Scolyer, R., Tembe, V., Vilain, R., Yang, J., deFazio, A., et al (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications, 11(1), 1-27. [More Information]
• Li, C., Prokopec, S., Sun, R., Yousif, F., Schmitz, N., Al-Shahrour, F., Atwal, G., Bailey, P., Biankin, A., Burke, H., et al (2020). Sex differences in oncogenic mutational processes. Nature Communications, 11(1), 4330. [More Information]
• Barbour, A., Samra, J., Haghighi, K., Donoghoe, M., Burge, M., Harris, M., Chua, Y., Mitchell, J., O’Rourke, N., Chan, H., Kench, J., et al (2020). The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer. Annals of Surgical Oncology, 27(7), 2506-2515. [More Information]
• Bonnichsen, M., Skacel, E., Kench, J., Kaffes, A., Saxena, P. (2020). The diagnostic yield of specimens obtained from endoscopic ultrasound guided fine needle biopsy of solid masses with the AcquireTM needle. International Journal of Gastrointestinal Intervention, 9(3), 106-110. [More Information]

2019

• Zhang, A., Chiam, K., Haupt, Y., Fox, S., Birch, S., Tilley, W., Butler, L., Knudsen, K., Comstock, C., Rasiah, K., Horvath, L., Kench, J., et al (2019). An Analysis of a Multiple Biomarker Panel to Better Predict Prostate Cancer Metastasis After Radical Prostatectomy. International Journal of Cancer, 144(5), 1151-1159. [More Information]
• Morrow, A., Hogden, E., Kang, Y., Steinberg, J., Canfell, K., Solomon, M., Kench, J., Gill, A., Shaw, T., Pachter, N., Taylor, N., et al (2019). Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol. Trials, 20(1), 1-12. [More Information]
• Srigley, J., Delahunt, B., Samaratunga, H., Billis, A., Cheng, L., Clouston, D., Evans, A., Furusato, B., Kench, J., Leite, K., et al (2019). Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation. Pathology, 51(5), 463-473. [More Information]
• Egevad, L., Judge, M., Delahunt, B., Humphrey, P., Kristiansen, G., Oxley, J., Rasiah, K., Takahashi, H., Trpkov, K., Varma, M., et al (2019). Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR). Pathology, 51(1), 11-20. [More Information]
• Kench, J., Judge, M., Delahunt, B., Humphrey, P., Kristiansen, G., Oxley, J., Rasiah, K., Takahashi, H., Trpkov, K., Varma, M., et al (2019). Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting. Virchows Archiv, 475(3), 263-277. [More Information]
• Skvortsova, K., Masle-Farquhar, E., Luu, P., Song, J., Qu, W., Zotenko, E., Gould, C., Du, Q., Peters, T., Kench, J., Horvath, L., et al (2019). DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns. Cancer Cell, 35(2), 297-314. [More Information]
• Bergamin, S., Eade, T., Kneebone, A., Kench, J., Sved, P., Biset, J., Hruby, G. (2019). Ductal Carcinoma of the Prostate: An Uncommon Entity With Atypical Behaviour. Clinical Oncology, 31(2), 108-114. [More Information]
• Mudaliar, S., Liu, K., Pavendranathan, G., Kench, J., Strasser, S. (2019). Hepatobiliary and Pancreatic: Kasabach-Merritt syndrome in adult. Journal of Gastroenterology and Hepatology, 34(10), 1675. [More Information]
• Arianayagam, R., Kench, J., Elder, G., Thanigasalam, R. (2019). Laparoscopic partial nephrectomy for Juxtaglomerular apparatus tumour: A rare cause of hypertension. Urology Case Reports, 26, 1-2. [More Information]
• Maharaj, A., Ioannou, L., Croagh, D., Zalcberg, J., Neale, R., Goldstein, D., Merrett, N., Kench, J., White, K., Pilgrim, C., Kneebone, A., Sandroussi, C., et al (2019). Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. HPB, 21(4), 444-455. [More Information]
• Quinn, D., Stricker, P., Kench, J., Grogan, J., Haynes, A., Henshall, S., Grygiel, J., Delprado, W., Turner, J., Horvath, L., Mahon, K. (2019). p53 nuclear accumulation as an early indicator of lethal prostate cancer. British Journal of Cancer, 121(7), 578-583. [More Information]
• Tay, K., Amin, M., Ghai, S., Jimenez, R., Kench, J., Klotz, L., Montironi, R., Muto, S., Rastinehad, A., Turkbey, B., et al (2019). Surveillance after prostate focal therapy. World Journal of Urology, 37(3), 397-407. [More Information]
• Raj, D., Yang, M., Rodgers, D., Hampton, E., Begum, J., Mustafa, A., Lorizio, D., Garces, I., Propper, D., Kench, J., et al (2019). Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Gut, 68(6), 1052-1064. [More Information]
• Baars, J., Keegan, M., Bonnichsen, M., Aepli, P., Theyventhiran, R., Farrel, E., Kench, J., Saxena, P., Kaffes, A. (2019). The ideal technique for processing SpyBite tissue specimens: a prospective, single-blinded, pilot-study of histology and cytology techniques. Endoscopy International Open, 7(10), E1241-E1247. [More Information]
• Maharaj, A., Holland, J., Scarborough, R., Evans, S., Ioannou, L., Brown, W., Croagh, D., Pilgrim, C., Kench, J., Lipton, L., et al (2019). The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. BMJ Open, 9(9), 1-11. [More Information]
• D'Avigdor, W., Budzinska, M., Lee, M., Lam, R., Kench, J., Stapelberg, M., McLennan, S., Farrell, G., George, J., McCaughan, G., Shackel, N., et al (2019). Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver. Scientific Reports, 9(1), 1-12. [More Information]

2018

• van Ramshorst, G., O'Shannassy, S., Brown, W., Kench, J., Solomon, M. (2018). A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer. Colorectal Disease, 20(11), 1004-1013. [More Information]
• Bonnichsen, M., Strasser, S., Liu, K., McCaughan, G., Kench, J., Caterson, H., McKenzie, C. (2018). Acute Antibody Mediated Rejection in Liver Transplant Recipients: A Cause of Severe Allograft Dysfunction and Graft Loss. Hepatology, 68(Suppl 1), 684A-684A. [More Information]
• Bonnichsen, M., Caterson, H., Liu, K., Kench, J., McKenzie, C., McCaughan, G., Strasser, S. (2018). Acute antibody-mediated rejection in liver transplant recipients: A cause of severe allograft dysfunction and graft loss. Journal of Gastroenterology and Hepatology, 33(Suppl 2), 36-36. [More Information]
• Kalsbeek, A., Chan, E., Grogan, J., Petersen, D., Jaratlerdsiri, W., Gupta, R., Lyons, R., Haynes, A., Horvath, L., Kench, J., Hayes, V., et al (2018). Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer. The Prostate, 78(1), 25-31. [More Information]
• Lin, H., Lee, B., Castillo, L., Spielman, C., Grogan, J., Yeung, N., Kench, J., Stricker, P., Haynes, A., Centenera, M., et al (2018). Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer. The Prostate, 78(4), 308-317. [More Information]
• Pidsley, R., Lawrence, M., Zotenko, E., Niranjan, B., Statham, A., Song, J., Chabanon, R., Qu, W., Wang, H., Richards, M., Kench, J., Horvath, L., et al (2018). Enduring epigenetic landmarks define the cancer microenvironment. Genome Research, 28(5), 625-638. [More Information]
• Nair, S., Luu, P., Qu, W., Maddugoda, M., Huschtscha, L., Reddel, R., Chenevix-Trench, G., Toso, M., Kench, J., Horvath, L., Hayes, V., Rasko, J., Wong, J., et al (2018). Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten. Epigenetics & Chromatin, 11(1), 1-20. [More Information]
• Henderson, J., Polak, N., Chen, J., Roediger, B., Weninger, W., Kench, J., McCaughan, G., Zhang, H., Gorrell, M. (2018). Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma. Scientific Reports, 8(1), 1-12. [More Information]
• Egevad, L., Delahunt, B., Berney, D., Bostwick, D., Cheville, J., Comperat, E., Evans, A., Fine, S., Grignon, D., Humphrey, P., Kench, J., et al (2018). Utility of Pathology Imagebase for standardisation of prostate cancer grading. Histopathology, 73(1), 8-18. [More Information]

2017

• Zhang, A., Grogan, J., Mahon, K., Rasiah, K., Sved, P., Eisinger, D., Boulas, J., Vasilaris, A., Henshall, S., Stricker, P., Kench, J., Horvath, L. (2017). A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer. Annals of Oncology, 28(8), 1903-1909. [More Information]
• Valdés-Mora, F., Gould, C., Colino-Sanguino, Y., Qu, W., Song, J., Taylor, K., Buske, F., Statham, A., Nair, S., Armstrong, N., Kench, J., Lee, K., Horvath, L., et al (2017). Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. Nature Communications, 8(1), 1346. [More Information]
• Aivazian, K., Long, G., Sinclair, E., Kench, J., McKenzie, C. (2017). Histopathology of pembrolizumab-induced hepatitis: a case report. Pathology, 49(7), 789-792. [More Information]
• Humphris, J., Patch, A., Nones, K., Bailey, P., Johns, A., McKay, S., Chang, D., Miller, D., Pajic, M., Samra, J., Kench, J., Gill, A., et al (2017). Hypermutation In Pancreatic Cancer. Gastroenterology, 152(1), 68-74.e2. [More Information]
• Egevad, L., Cheville, J., Evans, A., Hornblad, J., Kench, J., Kristiansen, G., Leite, K., Magi-Galluzzi, C., Pan, C., Samaratunga, H., et al (2017). Pathology Imagebase—a reference image database for standardization of pathology. Histopathology, 71(5), 677-685. [More Information]
• Grogan, J., Gupta, R., Mahon, K., Stricker, P., Haynes, A., Delprado, W., Turner, J., Horvath, L., Kench, J. (2017). Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up. BJU International, 120(5), 651-658. [More Information]
• Delahunt, B., Grignon, D., Samaratunga, H., Srigley, J., Leite, K., Kristiansen, G., Evans, A., Kench, J., Egevad, L. (2017). Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System. Archives of Pathology & Laboratory Medicine, 141(2), 182-183. [More Information]
• Scarpa, A., Chang, D., Nones, K., Corbo, V., Patch, A., Bailey, P., Lawlor, R., Johns, A., Miller, D., Lau, L., Lee, M., Pickett, H., Reddel, R., Samra, J., Kench, J., Gill, A., et al (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543(7643), 65-71. [More Information]

2016

• Liu, K., Joseph, D., Lai, K., Kench, J., Ngu, M. (2016). Abdominal actinomycosis presenting as appendicitis: two case reports and review. Journal of Surgical Case Reports, 2016 (5), 1-3. [More Information]
• Bailey, P., Chang, D., Nones, K., Johns, A., Patch, A., Gingras, M., Miller, D., Christ, A., Bruxner, T., Quinn, M., Samra, J., Kench, J., Gill, A., et al (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. [More Information]
• Egevad, L., Delahunt, B., Evans, A., Grignon, D., Kench, J., Kristiansen, G., Leite, K., Samaratunga, H., Srigley, J. (2016). International Society of Urological Pathology (ISUP) Grading of Prostate Cancer. The American Journal of Surgical Pathology, 40(6), 858-861. [More Information]
• Bruce, H., Stricker, P., Gupta, R., Savdie, R., Haynes, A., Mahon, K., Lin, H., Kench, J., Horvath, L. (2016). Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer. The Prostate, 76(16), 1491-1500. [More Information]
• Kalsbeek, A., Chan, E., Grogan, J., Petersen, D., Jaratlerdsiri, W., Gupta, R., Lyons, R., Haynes, A., Horvath, L., Kench, J., Hayes, V., et al (2016). Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer. Aging, 8(11), 2702-2712. [More Information]
• Gandy, R., Barbour, A., Samra, J., Nikfarjam, M., Haghighi, K., Kench, J., Saxena, P., Goldstein, D. (2016). Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Medical Journal of Australia, 204(11), 419-422. [More Information]

2015

• Matsika, A., Srinivasan, B., Day, C., Mader, S., Kiernan, D., Broomfield, A., Fu, J., Hooper, J., Kench, J., Samaratunga, H. (2015). Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2. Pathology, 47(7), 622-628. [More Information]
• Gupta, R., O'Connell, R., Haynes, A., Stricker, P., Barrett, W., Turner, J., Delprado, W., Horvath, L., Kench, J. (2015). Extraprostatic Extension (EPE) of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important? BJU International, 116(3), 343-350. [More Information]
• Rynkiewicz, N., Fedele, C., Chiam, K., Gupta, R., Kench, J., Ooms, L., McLean, C., Giles, G., Horvath, L., Mitchell, C. (2015). INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival. The Prostate, 75(1), 92-102. [More Information]
• Matthews, Y., McKenzie, C., Bryne, C., Kench, J. (2015). Intraductal tubulopapillary neoplasm of pancreas with associated invasive carcinoma, lymph node, rectal and hepatic metastases. Pathology, 47(2), 169-171. [More Information]
• Cheng, R., Cooper, A., Kench, J., Watson, G., Bye, W., McNeil, C., Shackel, N. (2015). Ipilimumab-induced toxicities and the gastroenterologist. Journal of Gastroenterology and Hepatology, 30(4), 657-666. [More Information]
• Chandrasegaram, M., Goldstein, D., Simes, R., Gebski, V., Kench, J., Gill, A., Samra, J., Merrett, N., Richardson, A., Barbour, A. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery, 102(12), 1459-1472. [More Information]
• Kitzing, Y., Ng, B., Kitzing, B., Waugh, R., Kench, J., Strasser, S., McCormack, S. (2015). Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. Journal of Medical Imaging and Radiation Oncology, 59(6), 673-680. [More Information]
• Waddell, N., Pajic, M., Patch, A., Chang, D., Kassahn, K., Bailey, P., Johns, A., Miller, D., Nones, K., Quek, K., Samra, J., Kench, J., Gill, A., et al (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518(7540), 495-501. [More Information]

2014

• McKenzie, P., Delahunt, B., Kench, J., Sikaris, K. (2014). 5-alpha reductase inhibitors and PSA screening for prostate cancer. Pathology, 46(1), 91-92. [More Information]
• Backhouse, A., Vasilaras, A., Yung, T., Kench, J. (2014). Adenocarcinoma arising within ectopic prostatic tissue in the urinary bladder. Pathology, 46(7), 655-657. [More Information]
• Nagrial, A., Chang, D., Nguyen, N., Johns, A., Chantrill, L., Humphris, J., Chin, V., Samra, J., Gill, A., Pajic, M., Kench, J., et al (2014). Adjuvant chemotherapy in elderly patients with pancreatic cancer. British Journal of Cancer, 110(2), 313-319. [More Information]
• Prakoso, E., Tirnitz-Parker, J., Clouston, A., Kayali, Z., Lee, A., Gan, E., Ramm, G., Kench, J., Bowen, D., Olynyk, J., McCaughan, G., Shackel, N. (2014). Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation. Liver Transplantation, 20(12), 1508-1519. [More Information]
• Humphris, J., Johns, A., Simpson, S., Cowley, M., Pajic, M., Chang, D., Nagrial, A., Chin, V., Chantrill, L., Pinese, M., Gill, A., Samra, J., Kench, J., et al (2014). Clinical and pathologic features of familial pancreatic cancer. Cancer, 120(23), 3669-3675. [More Information]
• Galletti, G., Matov, A., Beltran, H., Fontugne, J., Mosquera, J., Cheung, C., MacDonald, T., Sung, M., O'Toole, S., Kench, J., Horvath, L., et al (2014). ERG induces taxane resistance in castration-resistant prostate cancer. Nature Communications, 5, 1-12. [More Information]
• Birch, S., Kench, J., Takano, E., Chan, P., Chan, A., Chiam, K., Veillard, A., Stricker, P., Haupt, S., Haupt, Y., Horvath, L., et al (2014). Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death. Annals of Oncology, 25(12), 2392-2397. [More Information]
• Sutherland, S., Pe Benito, R., Henshall, S., Horvath, L., Kench, J. (2014). Expression of phosphorylated-mTOR during the development of prostate cancer. The Prostate, 74(12), 1231-1239. [More Information]
• Yip, P., Cooper, W., Kohonen-Corish, M., Lin, B., McCaughan, B., Boyer, M., Kench, J., Horvath, L. (2014). Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer. Journal of Clinical Pathology, 67(4), 333-340. [More Information]

2013

• Gzell, C., Kench, J., Stockler, M., Hruby, G. (2013). Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature. International Urology and Nephrology, 45(3), 735-742. [More Information]
• Cooper, C., O'Toole, S., Kench, J. (2013). Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology, 45(3), 286-304. [More Information]
• Kench, J., Delahunt, B., Griffiths, D., Humphrey, P., McGowan, T., Trpkov, K., Varma, M., Wheeler, T., Srigley, J. (2013). Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology, 62(2), 203-218. [More Information]
• Cooper, W., Yu, B., Yip, P., Ng, C., Lum, T., Farzin, M., Trent, R., Mercorella, B., Clarkson, A., Kohonen-Corish, M., Horvath, L., Kench, J., McCaughan, B., Gill, A., O'Toole, S. (2013). EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma. Journal of Clinical Pathology, 66(9), 744-748. [More Information]
• Hulf, T., Sibbritt, T., Wiklund, E., Patterson, K., Song, J., Stirzaker, C., Qu, W., Nair, S., Horvath, L., Armstrong, N., et al (2013). Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. Oncogene, 32(23), 2891-2899. [More Information]
• Coker, D., Kench, J., Ansari, N., Zhou, R., Sandroussi, C. (2013). Hepatobiliary and Pancreatic: Clear cell myomelanotic tumor of ligamentum teres. Journal of Gastroenterology and Hepatology, 28(2), 381-381. [More Information]
• Chang, D., Jamieson, N., Johns, A., Scarlett, C., Pajic, M., Chou, A., Pinese, M., Humphris, J., Jones, M., Toon, C., Samra, J., Kench, J., Gill, A., et al (2013). Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater. Journal of Clinical Oncology, 31(10), 1348-1356. [More Information]
• Hashemi, S., van der Poorten, D., Barrera Martinez, F., Bandara, P., Lux, O., Kench, J., George, J. (2013). Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International, 7(2), 516-523. [More Information]
• Yip, P., Yu, B., Cooper, W., Selinger, C., Ng, C., Kennedy, C., Kohonen-Corish, M., McCaughan, B., Trent, R., Boyer, M., Kench, J., Horvath, L., O'Toole, S. (2013). Patterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma. Journal of Thoracic Oncology, 8(4), 408-414. [More Information]
• McKenzie, P., Delahunt, B., Kench, J., Ross, B., Lam, Q., DeVoss, K., Tran, H., Sikaris, K. (2013). Prostate specific antigen testing: age-related interpretation in early prostate cancer detection. Pathology, 45(4), 343-345. [More Information]
• Young, J., Ting, K., Li, J., Moller, T., Dunn, L., Lu, Y., Moses, J., Prado-Lourenco, L., Khachigian, L., Ng, M., Lichtenstein, I., Tran, N., Shackel, N., Kench, J., McCaughan, G., Vadas, M., Gamble, J., et al (2013). Regulation of vascular leak and recovery from ischaemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood, 122(16), 2911-2919. [More Information]
• Pang, J., Mahar, A., Shannon, K., Kench, J., Chan, C., Gupta, R. (2013). Reticular and microcystic schwannoma of the parotid gland. Pathology, 45(1), 96-98. [More Information]
• McKenzie, P., Delahunt, B., Kench, J. (2013). The dilemmas of prostate cancer screening. Medical Journal of Australia, 199(9), 582-584. [More Information]

2012

• Ramponi, F., Kench, J., Simring, D., Crawford, M., Abadir, E., Harris, J. (2012). Early diagnosis and resection of an asymptomatic leiomyosarcoma of the inferior vena cava prior to caval obstruction. Journal Of Vascular Surgery, 55(2), 525-528. [More Information]
• Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]
• Savdie, R., Horvath, L., Pe Benito, R., Rasiah, K., Haynes, A., Chatfield, M., Stricker, P., Turner, J., Delprado, W., Henshall, S., Kench, J., et al (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109(12), 1794-1800. [More Information]
• Biankin, A., Waddell, N., Kassahn, K., Gingras, M., Muthuswamy, L., Johns, A., Miller, D., Wilson, P., Patch, A., Wu, J., Gill, A., Kench, J., Pavlakis, N., Lam, V., Richardson, A., Samra, J., et al (2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491(7424), 399-405. [More Information]
• Humphris, J., Chang, D., Johns, A., Scarlett, C., Pajic, M., Jones, M., Colvin, E., Nagrial, A., Chin, V., Chantrill, L., Samra, J., Gill, A., Kench, J., et al (2012). The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Annals of Oncology, 23(7), 1713-1722. [More Information]

2011

• Nguyen, N., Johns, A., Gill, A., Ring, N., Chang, D., Clarkson, A., Merrett, N., Kench, J., Colvin, E., Scarlett, C., et al (2011). Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. Journal of Gastroenterology and Hepatology, 26(2), 267-274. [More Information]
• Devaney, J., Stirzaker, C., Qu, W., Song, J., Statham, A., Patterson, K., Horvath, L., Tabor, B., Coolen, M., Hulf, T., Kench, J., et al (2011). Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers. Cancer Epidemiology Biomarkers and Prevention, 20(1), 148-159. [More Information]
• Kwong, R., Scarlett, C., Kalish, L., Cole, I., Kench, J., Sum, E., Musgrove, E., Henshall, S., Lindeman, G., Biankin, A., et al (2011). LMO4 expression in squamous cell carcinoma of the anterior tongue. Histopathology, 58(3), 477-480. [More Information]
• Yip, P., Kench, J., Rasiah, K., Pe Benito, R., Lee, C., Stricker, P., Henshall, S., Sutherland, R., Horvath, L. (2011). Low AZGPI Expression Predicts for Recurrence in Margin-Positive, Localized Prostate Cancer. The Prostate, 71(15), 1638-1645. [More Information]
• Scarlett, C., Salisbury, E., Biankin, A., Kench, J. (2011). Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology, 43(3), 183-200. [More Information]
• Kench, J., Clouston, D., Delprado, W., Eade, T., Ellis, D., Horvath, L., Samaratunga, H., Stahl, J., Stapleton, A., Egevad, L., et al (2011). Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology, 43(5), 410-419. [More Information]
• Scarlett, C., Colvin, E., Pinese, M., Chang, D., Morey, A., Musgrove, E., Pajic, M., Apte, M., Henshall, S., Sutherland, R., et al (2011). Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction. PloS One, 6(10), 0-8. [More Information]
• Colvin, E., Susanto, J., Kench, J., Ong, V., Mawson, A., Pinese, M., Chang, D., Rooman, I., O'Toole, S., Segara, D., et al (2011). Retinoid signaling in pancreatic cancer, injury and regeneration. PloS One, 6(12), e29075 - 1-e29075 - 10. [More Information]

2010

• Callen, D., Ricciardelli, C., Butler, M., Stapleton, A., Stahl, J., Kench, J., Horsefall, D., Tilley, W., Schulz, R., Nesland, J., et al (2010). Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome. Oncology Reports, 23(4), 1045-1052. [More Information]
• Ricciardelli, C., Bianco-Miotto, T., Jindal, S., Dodd, T., Cohen, P., Marshall, V., Sutherland, P., Samaratunga, H., Kench, J., Dong, Y., et al (2010). Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies. Cancer Epidemiology Biomarkers and Prevention, 19(7), 1755-1765. [More Information]
• Talantov, D., Jatkoe, T., Bohm, M., Zhang, Y., Ferguson, A., Stricker, P., Kattan, M., Sutherland, R., Kench, J., Wang, Y., et al (2010). Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. The Journal of Urology, 184(4), 1521-1528. [More Information]
• Bianco-Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T., Thomas, M., Pickering, M., O'Loughlin, M., Ryan, N., Raymond, W., Horvath, L., Kench, J., et al (2010). Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development. Cancer Epidemiology Biomarkers and Prevention, 19(10), 2611-2622. [More Information]
• Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S., Hawthorne, W., O'Connell, P., Loudovaris, T., Kay, T., Kulkarni, R., Biankin, A., Kench, J., Gunton, J., et al (2010). Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. Journal of Clinical Investigation, 120(6), 2171-2183. [More Information]
• Hudson, T., Anderson, W., Aretz, A., Barker, A., Bell, C., Bernabe, R., Bhan, M., Calvo, F., Eerola, I., Gerhard, D., deFazio, A., Kench, J., et al (2010). International network of cancer genome projects. Nature, 464, 993-998. [More Information]

2009

• Bohm, M., Locke, W., Sutherland, R., Kench, J., Henshall, S. (2009). A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene, 28(43), 3847-3856. [More Information]
• Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology, 49(6), 1926-1934. [More Information]
• Biankin, A., Kench, J., Colvin, E., Segara, D., Scarlett, C., Nguyen, N., Chang, D., Morey, A., Lee, C., Pinese, M., et al (2009). Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer. Gastroenterology, 137(2), 558-568. [More Information]
• Kench, J., Rasiah, K., Gardiner-Garden, M., Padilla, E., Moller, G., Alles, M., Eggleton, S., Stricker, P., Adamski, J., Sutherland, R. (2009). HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer. Molecular And Cellular Endocrinology, 301`, 89-96. [More Information]
• Chang, D., Johns, A., Merrett, N., Gill, A., Colvin, E., Scarlett, C., Nguyen, N., Leong, R., Cosman, P., Kelly, M., Kench, J., et al (2009). Margin Clearance and Outcome in Resected Pancreatic Cancer. Journal of Clinical Oncology, 27(17), 2855-2862. [More Information]
• Pinese, M., Scarlett, C., Kench, J., Colvin, E., Segara, D., Henshall, S., Sutherland, R., Biankin, A. (2009). Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease. PloS One, 4(4), e5337-1-e5337-7. [More Information]
• Nguyen, N., Biankin, A., Leong, R., Chang, D., Cosman, P., Delaney, P., Kench, J., Merrett, N. (2009). Real time intraoperative confocal laser microscopy-guided surgery. Annals of Surgery, 249(5), 735-737. [More Information]
• Gill, A., Johns, A., Eckstein, R., Samra, J., Kaufman, A., Chang, D., Merrett, N., Cosman, P., Smith, R., Biankin, A., et al (2009). Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology, 41(2), 161-167. [More Information]

2008

• Ho, L., Kench, J., Handelsman, D., Scheffer, G., Stricker, P., Grygiel, J., Sutherland, R., Henshall, S., Allen, J., Horvath, L. (2008). Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. The Prostate, 68(13), 1421-1429. [More Information]
• Murphy, N., Scarlett, C., Kench, J., Sum, E., Colvin, E., Susanto, J., Cosman, P., Lee, C., Musgrove, E., Sutherland, R., et al (2008). Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. British Journal of Cancer, 98(3), 537-541. [More Information]
• Cua, I., Hui, J., Kench, J., George, J. (2008). Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology, 48(3), 723-731. [More Information]
• Sakko, A., Butler, M., Byers, S., Reinboth, B., Stahl, J., Kench, J., Horvath, L., Sutherland, R., Stricker, P., Henshall, S., et al (2008). Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiology Biomarkers and Prevention, 17(9), 2488-2497. [More Information]
• Poustchi, H., Negro, F., Hui, J., Cua, I., Brandt, L., Kench, J., George, J. (2008). Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. Journal of Hepatology, 48(1), 28-34. [More Information]
• Kench, J., Cosman, P., Merrett, N., Biankin, A. (2008). Pathology and Molecular Biology of Intraductal Papillary Mucinous Neoplasms. In Andrew M. Lowy, Steven D. Leach, Philip A. Philip (Eds.), Pancreatic Cancer, (pp. 53-64). New York, US: Springer.
• Heiser, P., Cano, D., Landsman, L., Kim, G., Kench, J., Klimstra, D., Taketo, M., Biankin, A., Hebrok, M. (2008). Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology, 135(4), 1288-1300. [More Information]
• van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, A., Chisholm, D., George, J. (2008). Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2), 449-457. [More Information]

2007

• di Magliano, M., Biankin, A., Heiser, P., Cano, D., Gutierrez, P., Deramaudt, T., Segara, D., Dawson, A., Kench, J., Henshall, S., et al (2007). Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PloS One, 2(11), 1-9. [More Information]
• Laybutt, D., Preston, A., Akerfeldt, M., Kench, J., Busch, A., Biankin, A., Biden, T. (2007). Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia, 50(4), 752-763. [More Information]
• Cua, I., Hui, J., Bandara, P., Kench, J., Farrell, G., McCaughan, G., George, J. (2007). Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology, 46(1), 66-73. [More Information]
• Oakes, S., Robertson, F., Kench, J., Gardiner-Garden, M., Wand, M., Green, J., Ormandy, C. (2007). Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene, 26(4), 543-553. [More Information]
• Horvath, L., Lelliott, J., Kench, J., Lee, C., Williams, E., Saunders, D., Grygiel, J., Sutherland, R., Henshall, S. (2007). Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. The Prostate, 67(10), 1081-1090. [More Information]
• Angulo, P., Hui, J., Marchesini, G., Bugianesi, E., George, J., Farrell, G., Enders, F., Saksena, S., Burt, A., Bida, J., Kench, J., et al (2007). The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45(4), 846-854. [More Information]

2006

• Rasiah, K., Kench, J., Gardiner-Garden, M., Biankin, A., Golovsky, D., Brenner, P., Kooner, R., O'Neill, G., Turner, J., Delprado, W., Lee, C., Horvath, L., et al (2006). Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiology Biomarkers and Prevention, 15(4), 711-716. [More Information]
• McNeil, C., Sergio, C., Anderson, L., Inman, C., Eggleton, S., Murphy, N., Millar, E., Crea, P., Kench, J., Alles, M., Ormandy, C., Butt, A., et al (2006). c-Myc overexpression and endocrine resistance in breast cancer. Journal of Steroid Biochemistry and Molecular Biology. [More Information]
• Skalicky, D., Kench, J., Segara, D., Coleman, M., Sutherland, R., Henshall, S., Musgrove, E., Biankin, A. (2006). Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention, 15(10), 1941-1947. [More Information]
• Cua, I., Hui, J., Bandara, P., Kench, J., McCaughan, G., George, J. (2006). Is insulin resistance and liver injury in chronic hepatitis C associated with virus-specific alteration in the levels of serum adipocytokines? Journal of Gastroenterology and Hepatology, 21, A22-A22.
• Cua, I., Kwan, V., Henriquez, M., Kench, J., George, J. (2006). Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis. Gut, 55(10), 1521-1522. [More Information]
• Henshall, S., Horvath, L., Quinn, D., Eggleton, S., Grygiel, J., Stricker, P., Biankin, A., Kench, J., Sutherland, R. (2006). Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. Journal of the National Cancer Institute, 98(19), 1420-1424. [More Information]

2005

• Bandara, P., George, J., McCaughan, G., Naidoo, D., Lux, O., Salonikas, C., Kench, J., Byth Wilson, K., Farrell, G. (2005). Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C. Liver International, 25(3), 518-526. [More Information]
• Segara, D., Biankin, A., Kench, J., Langusch, C., Dawson, A., Skalicky, D., Gotley, D., Coleman, M., Sutherland, R., Henshall, S. (2005). Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clinical Cancer Research, 11(9), 3587-3596. [More Information]
• Adams, L., Bulsara, M., Rossi, E., DeBoer, B., Speers, D., George, J., Kench, J., Farrell, G., McCaughan, G., Jeffrey, G. (2005). Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chemistry, 51(10), 1867-1873. [More Information]
• Kumar, U., Farrell, G., Kench, J., George, J. (2005). Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C. Journal of Gastroenterology and Hepatology, 20(9), 1395-1400. [More Information]
• Horvath, L., Henshall, S., Lee, C., Kench, J., Golovsky, D., Brenner, P., O'Neill, G., Kooner, R., Stricker, P., Grygiel, J., et al (2005). Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. International Journal of Cancer, 113(3), 415-422. [More Information]
• Kwong, R., Kalish, L., Nguyen, T., Kench, J., Bova, R., Cole, I., Musgrove, E., Sutherland, R. (2005). p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Clinical Cancer Research, 11(11), 4107-4116. [More Information]
• Cachia, A., Eshoo, S., Kench, J., Fung, C., Jones, A., Iredell, J., Don, G. (2005). Synchronous malakoplakia and Whipple's disease. Pathology, 37(4), 315-7. [More Information]
• Bauskin, A., Brown, D., Junankar, S., Rasiah, K., Eggleton, S., Hunter, M., Liu, T., Smith, D., Kuffner, T., Kench, J., et al (2005). The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Research, 65(6), 2330-2336. [More Information]

2004

• Hui, J., Hodge, A., Farrell, G., Kench, J., Kriketos, A., George, J. (2004). Beyond Insulin Resistance In Nash: Tnf-Alpha Or Adiponectin? Hepatology, 40(1), 46-54. [More Information]
• Coverdale, S., Khan, M., Byth Wilson, K., Lin, R., Weltman, M., George, J., Samarasinghe, D., Liddle, C., Farrell, G., Kench, J., Crewe, E. (2004). Effects Of Interferon Treatment Response On Liver Complications Of Chronic Hepatitis C: 9-Year Follow-Up Study. American Journal of Gastroenterology, 99(4), 636-644. [More Information]
• Hui, J., Farrell, G., Kench, J., George, J. (2004). High sensitivity C-reactive protein values do not reliably predict the severity of histological change in NAFLD. Hepatology, 39(5), 1458-1459. [More Information]
• Sud, A., Hui, J., Farrell, G., Bandara, P., Kench, J., Fung, C., Lin, R., Samarasinghe, D., Liddle, C., McCaughan, G., George, J. (2004). Improved Prediction Of Fibrosis In Chronic Hepatitis C Using Measures Of Insulin Resistance In A Probability Index. Hepatology, 39(5), 1239-1247. [More Information]
• Horvath, L., Henshall, S., Kench, J., Saunders, D., Lee, C., Golovsky, D., Brenner, P., O’Neill, G., Kooner, R., Stricker, P., et al (2004). Membranous Expression Of Secreted Frizzled-Related Protein 4 Predicts For Good Prognosis In Localized Prostate Cancer And Inhibits Pc3 Cellular Proliferation In Vitro. Clinical Cancer Research, 10(2), 615-625. [More Information]
• Heinzelmann-Schwarz, V., Gardiner-Garden, M., Henshall, S., Scurry, J., Scolyer, R., Davies, M., Heinzelmann, M., Kalish, L., Bali, A., Kench, J., et al (2004). Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clinical Cancer Research, 10(13), 4427-4436. [More Information]
• Biankin, A., Kench, J., Biankin, S., Soon, L., Morey, A., Dijkman, F., Coleman, M., Sutherland, R., Henshall, S. (2004). Pancreatic Intraepithelial Neoplasia In Association With Intraductal Papillary Mucinous Neoplasms Of The Pancreas: Implications For Disease Progression And Recurrence. American Journal of Surgical Pathology, 28(9), 1184-1192. [More Information]
• Afar, D., Bhaskar, V., Ibsen, E., Breinberg, D., Henshall, S., Kench, J., Drobnjak, M., Powers, R., Wong, M., Evangelista, F., et al (2004). Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Molecular Cancer Therapeutics, 3(8), 921-932. [More Information]

2003

• Coverdale, S., Samarasinghe, D., Lin, R., Kench, J., Byth Wilson, K., Khan, M., Crewe, E., Liddle, C., George, J., Farrell, G. (2003). Changes in Antipyrine Clearance and Platelet Count, but Not Conventional Liver Tests, Correlate With Fibrotic Change in Chronic Hepatitis C: Value for Predicting Fibrotic Progression. American Journal of Gastroenterology, 98(6), 1384-1390. [More Information]
• Hui, J., Sud, A., Farrell, G., Bandara, P., Byth Wilson, K., Kench, J., McCaughan, G., George, J. (2003). Insulin resistance is associated with chronic Hepatitis C and virus infection fibrosis progression. Gastroenterology, 125(6), 1695-1704. [More Information]
• Veness, M., Thompson, S., Morgan, G., Shannon, J., Kench, J. (2003). Leptomeningeal carcinomatosis from squamous cell carinoma of the surpaglottic larynx. Journal of Medical Imaging and Radiation Oncology, 11, 325-330. [More Information]
• Hui, J., Kench, J., Chitturi, S., Sud, A., Farrell, G., Blyth, K., Hall, P., Khan, M., George, J. (2003). Long term outcomes of cirrhosis in nonalcoholic steatohepatitis compares with hepatitis c. Hepatology, 38(2), 420-427. [More Information]
• Biankin, A., Kench, J., Dijkman, F., Biankin, S., Henshall, S. (2003). Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology, 35(1), 14-24. [More Information]
• Kwong, R., Nguyen, T., Bova, R., Kench, J., Cole, I., Musgrove, E., Henshall, S., Sutherland, R. (2003). Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clinical Cancer Research, 9(10), 3705-3711. [More Information]
• Lee, D., Chitturi, S., Kench, J., George, J., Fuller, S., Bradstock, K., Lin, R., Wong, K., Young, N. (2003). Transjugular liver biopsy effecting changes in clinical management. Journal of Medical Imaging and Radiation Oncology, 47(2), 117-120. [More Information]

2002

• Biankin, A., Biankin, S., Kench, J., Morey, A., Lee, C., Head, D., Eckstein, R., Hugh, T., Henshall, S., Sutherland, R. (2002). Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut, 50, 861-868.
• Biankin, A., Morey, A., Lee, C., Kench, J., Biankin, S., Hook, H., Head, D., Hugh, T., Sutherland, R., Henshall, S. (2002). DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma. Journal of Clinical Oncology, 20(23), 4531-4542. [More Information]
• Chitturi, S., George, J., Ranjitkumar, S., Kench, J., Benson, W. (2002). Exchange Transfusion for Severe Intrahepatic Cholestasis Associated With Sickle Cell Disease. Journal of Clinical Gastroenterology, 35(4), 362-363. [More Information]
• Hui, J., Kench, J., Farrell, G., Lin, R., Samarasinghe, D., Liddle, C., Byth, K., George, J. (2002). Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. Journal of Gastroenterology and Hepatology, 17(8), 873-881. [More Information]
• Chitturi, S., Le, V., Kench, J., Loh, C., George, J. (2002). Gliclazide-Induced Acute Hepatitis with Hypersensitivity Features. Digestive Diseases and Sciences, 47(5), 1107-1110. [More Information]
• Hui, J., Farrell, G., Lin, R., Samarasinghe, D., Liddle, C., George, J., Kench, J., Byth, K. (2002). Hepatic Steatosis in Chronic Hepatitis C Infection. Journal of Gastroenterology and Hepatology, 17(8), 873-881.

2001

• Lee, C., Biankin, A., Kench, J., Morey, A., Biankin, S., Head, D., Hugh,, T., Henshall, S., Sutherland, A. (2001). Overexpression of p21WAF1/CP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia. Cancer Research, 61, 8830-8837.
• Coverdale, S., Samarasinghe, D., Lin, R., Liddle, C., George, J., Farrell, G., Kench, J., Byth, K., Khan, M., Crewe, E. (2001). Prediction of histological progression in chronic hepatitis C. Asia Pacific Digestive Week 2001, : World Scientific Publishing.
• George, J., Hui, J., Farrell, G., Lin, R., Samarasinghe, D., Kench, J. (2001). Predictors for steatosis and fibrosis in chronic hepatitis C. Journal of Hepatology, 34, 153-153.